LYMPH NODE RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH STAGE III RECTAL CANCER TREATED WITH TOTAL MESORECTAL EXCISION FOLLOWED BY CHEMORADIOTHERAPY
|
|
- Coleen Anthony
- 5 years ago
- Views:
Transcription
1 doi: /j.ijrobp Int. J. Radiation Oncology Biol. Phys., Vol. 74, No. 3, pp , 2009 Copyright Ó 2009 Elsevier Inc. Printed in the USA. All rights reserved /09/$ see front matter CLINICAL INVESTIGATION Rectum LYMPH NODE RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH STAGE III RECTAL CANCER TREATED WITH TOTAL MESORECTAL EXCISION FOLLOWED BY CHEMORADIOTHERAPY YOUNG SEOK KIM, M.D.,* JONG HOON KIM, M.D., PH.D.,* SANG MIN YOON, M.D.,* EUN KYUNG CHOI, M.D., PH.D.,* SEUNG DO AHN, M.D., PH.D.,* SANG-WOOK LEE, M.D., PH.D.,* JIN CHEON KIM, M.D., PH.D., y CHANG SIK YU, M.D., PH.D., y HEE CHUL KIM, M.D., PH.D., y TAE WON KIM, M.D., PH.D., z AND HEUNG MOON CHANG, M.D., PH.D. z Departments of *Radiation Oncology, y Colon and Rectal Surgery, and z Internal Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea Purpose: To investigate the prognostic impact of lymph node ratio (LNR) on survival in the patients with Stage III rectal cancer. Methods and Materials: We retrospectively reviewed the data of 421 consecutive patients who underwent total mesorectal excision followed by chemoradiotherapy for rectal cancer from 1996 to The 232 patients with positive lymph nodes (LNs) were divided into four groups according to LNR quartiles: LNR #0.1 (n = 69), #0.2 (n = 49), #0.4 (n = 54), and >0.4 (n = 60). The association between LNR and survival was evaluated by the Kaplan-Meier method and multivariate analysis with covariates of prognostic significance in univariate analysis. Results: The median numbers of examined and positive LNs were 17 and 3, respectively, and the median LNR was 0.20 (range, ). There was a strong correlation between the number of positive LNs and LNR (r = 0.724, p < 0.001). After a median follow-up of 53 months (range, months), the actuarial overall survival and diseasefree survival rates at 5 years were 69% and 56%, respectively. The ear survival rate decreased as LNR increased (#0.1, 89%; #0.2, 67%; #0.4, 64%; >0.4, 50%; p < 0.001). Lymph node ratio was also a significant prognostic factor on Cox regression analysis (#0.1, hazard ratio [HR] = 1; #0.2, HR = 1.3, p = 0.623; #0.4, HR = 2.4, p = 0.047; >0.4, HR = 3.7, p = 0.005). Lymph node ratio had a prognostic effect on overall survival in subgroups of patients with N1 (p = 0.032) and N2 (p = 0.034) tumors. Conclusion: Lymph node ratio was the most significant predictor of survival in the patients with Stage III rectal cancer who had undergone postoperative chemoradiation. Ó 2009 Elsevier Inc. Rectal cancer, Prognosis, Lymph node. INTRODUCTION Colorectal cancer is the fourth most common malignancy worldwide, accounting for 9.7% of all cancers and with 780,000 new cases detected annually (1). Approximately one third of these tumors are rectal cancers. The most important prognostic factor for colorectal cancer is disease stage. For example, the ear overall survival (OS) rate in patients with Stage II, or node-negative disease, is approximately 80%, declining to 50% in patients with Stage III, or nodepositive disease (2). Lymph node (LN) staging can be subdivided according to the number of positive LNs (N1, Stage IIIA or IIIB, three or fewer positive LNs; N2, Stage IIIC, more than three positive LNs). Both the American Joint Committee on Cancer and the International Union Against Cancer have estimated that the minimum number of LNs required for accurate staging of nodal status is 12. Lymph node yield in a surgical specimen positively correlates with tumor size, number of involved LNs, and examining pathologist (3). Although the number of examined LNs has been shown to be an independent prognostic factor for OS in patients with colorectal cancer, there is no consensus as to the optimal number of LNs that should be examined (4 10). Rather, the ratio of positive LNs to examined LNs, or lymph node ratio (LNR), has been shown to be an important prognostic factor in pancreatic, breast, bladder, and gastric cancers (11 17), as well as in colorectal cancer (18 20). Relatively little is known regarding the correlation between LNR and survival in patients with node-positive rectal Note An online CME test for this article can be taken at asro.astro.org under Continuing Education. Reprint requests to: Jong Hoon Kim, M.D., Department of Radiation Oncology, Asan Medical Center, University of Ulsan, 388-1, PoongNap-Dong, SongPa-Gu, Seoul, Korea. Tel: (+82) ; Fax: (+82) ; jhkim2@amc.seoul.kr Conflict of interest: none. Received May 23, 2008, and in revised form Aug 28, Accepted for publication Aug 29, 2008.
2 Prognostic value of LNR in rectal cancer d Y. S. KIM et al. 797 cancer. Because most studies that have addressed this issue included all patients with colorectal cancer, without separating out patients with rectal cancer from those with other colorectal malignancies, the results obtained may be hard to apply to Stage III rectal cancer patients. We therefore reviewed the clinical data from two prospective studies in a single institution to confirm whether LNR has prognostic value for survival in patients with Stage III rectal cancer. METHODS AND MATERIALS Patients Between February 1996 and February 2006, a total of 528 consecutive patients with pathologically proven Stage II and III rectal cancer were enrolled into two prospective randomized clinical trials at Asan Medical Center. Of these, 308 patients were included in a study of the optimal sequence of postoperative chemotherapy and radiotherapy (21), and 220 were included in a study comparing preand postoperative chemoradiotherapy (22). Exact LN status was obtained for 421 of these patients who had undergone postoperative chemoradiation. We excluded the 189 patients without metastatic LN, leaving 232 patients as our study population. Treatment and follow-up evaluation All patients underwent total mesorectal excision (TME), performed by three colorectal surgeons (J.C.K., C.S.Y., and H.C.K.). Postoperative chemoradiation was usually initiated within 4 8 weeks after surgery. The 308 patients in the earlier trial received fluorouracil 375 mg/m 2 /d plus leucovorin 20 mg/m 2 /d (21), for 3 days per 4-week cycle in the first two cycles, concurrent with radiotherapy, and for 5 days in the remaining four cycles. The remaining 113 patients received capecitabine (1,650 mg/m 2 /d) concurrent with radiotherapy and four cycles of fluorouracil/leucovorin, as above (22). Postoperative radiotherapy consisted of Gy in 25 fractions delivered to the pelvis using a three- or four-field box technique. History-taking, physical examination including digital rectal examination, complete blood count, carcinoembryonic antigen (CEA), chemistry, and chest X-ray were performed every 3 months for 2 years and repeated every 6 months thereafter. Computed tomography of the abdomen and pelvis was performed every 6 months for 2 years and then every 12 months. Colonoscopic examination was repeated every 12 months. The median follow-up period of the study population was 53 months (range, months). Statistical analysis The primary aim of this study was to investigate the prognostic significance of LNR on OS. Secondary endpoints included disease-free survival (DFS), local recurrence-free survival (LRFS), and distant metastasis-free survival (DMFS). Overall survival time was counted from the date of surgery to date of death or last follow-up. Patients were censored in the DFS analysis if they were disease-free at last visit, but death, regardless of final status, was counted as an event in the survival analysis. Local recurrence was defined as any recurrence within the radiation field, and distant metastasis as outside the field. The first site of recurrence was recognized if both local and distant failure occurred together. Statistical analyses were performed using SPSS 12.0 (SPSS, Chicago, IL). The Kaplan-Meier method was used to construct survival curves, and the log rank test was used to compare survival outcome. Multivariate analysis of independent prognostic factors for survival was determined using Cox regression. Chi-squared tests and analysis of Fig. 1. Correlation between lymph node ratio and number of positive lymph nodes (LNs). variance were used to compare between-group patient characteristics according to LNR. All p values were two-sided. RESULTS A total of 4,461 LNs were examined from 232 patients, with a median harvest of 17 LNs per specimen; of these 1,167 LNs (26%) were diagnosed as positive. A strong, positive correlation was observed between metastatic LNs and LNR as a continuous variable (correlation coefficient = 0.724; p<0.001; Fig. 1). In addition, a positive correlation was observed between the numbers of examined and positive LNs (r = 0.429; p<0.001). On the basis of LNR quartiles, the patients were categorized into four groups: LNR #0.1 (n = 69), #0.2 (n = 49), #0.4 (n = 54), and >0.4 (n = 60). Clinical and pathologic characteristics of the patients are summarized in Table 1. Median age was 54 years (range, years), and the majority had moderately differentiated T3 tumors of median size 5 cm (range, cm). The median distance from the anal verge to the most distal part of the tumor was 7 cm, and 89 patients (38%) had low-lying tumors, within 5 cm of the anal verge. Sphincter preservation was impossible in one third of these patients. The study population was evenly distributed across the four groups, except for N stage and the number of positive LNs. Patients with higher LNR had a higher number of metastatic LNs and more frequent N2 disease, owing to the strong correlation between LNR and positive LNs; however, the number of examined LNs was not significantly affected by LNR. The CEA level was increased in 67 of the 232 patients (29%) but did not differ significantly among the four LNR groups. Using the Kaplan-Meier method, we performed survival analyses for OS, LRFS, DMFS, and DFS. The ear OS and DFS rates for the 232 patients with Stage III rectal cancer were 69% and 56%, respectively. Distant metastasis was
3 798 I. J. Radiation Oncology d Biology d Physics Volume 74, Number 3, 2009 Table 1. Patient characteristics Characteristics #0.1 (n = 69) #0.2 (n = 49) #0.4 (n = 54) >0.4 (n = 60) Total (n = 232) Age (years) 56 (33 78) 56 (34 76) 51 (29 72) 53 (22 73) 54 (22 78) Gender Male 45 (65) 26 (53) 31 (57) 20 (50) 132 (57) Female 24 (35) 23 (47) 23 (43) 30 (50) 100 (43) CEA level (ng/ml) 4.3 ( ( ) 4.0 (0.6 48) 4.3 ( ) 4.2 ( ) T stage 1 1 (1) 2 (4) 1 (2) 1 (2) 5 (2) 2 12 (17) 2 (4) 1 (2) 1 (2) 16 (7) 3 55 (80) 40 (82) 47 (87) 53 (88) 195 (84) 4 1 (1) 5 (10) 5 (9) 5 (8) 16 (7) N stage* 1 68 (99) 34 (69) 15 (28) 7 (12) 124 (53) 2 1 (1) 15 (31) 39 (72) 53 (88) 108 (47) LNs examined 21 (10 44) 18 (7 43) 16 (4 61) 16 (3 58) 17 (3 61) LNs positive* 1 (1 4) 3 (1 5) 5 (1 16) 9 (2 42) 3 (1 42) Differentiation Well 5 (7) 2 (4) 3 (6) 3 (5) 13 (6) Moderately 58 (84) 41 (84) 39 (72) 35 (58) 173 (75) Poorly 2 (3) 4 (8) 3 (6) 15 (25) 24 (10) Others 4 (6) 2 (4) 9 (17) 7 (12) 22 (9) Tumor size (cm) 5.0 ( ) 5.5 ( ) 5.0 ( ) 5.0 ( ) 5.0 ( ) Operation APR 14 (20) 18 (37) 16 (30) 26 (43) 74 (32) LAR 54 (78) 30 (61) 38 (70) 33 (55) 155 (67) Others 1 (1) 1 (2) 0 (0) 1 (2) 3 (1) Abbreviations: LNR = lymph node ratio; CEA = carcinoembryonic antigen; LN = lymph node; APR = abdominoperineal resection; LAR = low anterior resection. Values are number (percentage) or median (range). Because of rounding, not all percentages total 100. * Statistically significant (p < in both parameters). LNR observed in 87 patients, and local recurrence in 22. The 5- year LRFS and DMFS rates were 89% and 62%, respectively. Overall survival curves among the four LNR groups differed significantly (Fig. 2); the ear OS rates of patients with LNR #0.1, #0.2, #0.4, and >0.4 were 89%, 67%, 64%, and 50%, respectively (p <0.001). In addition, the DFS curves among the four LNR groups differed significantly (Fig. 3); the ear DFS rates of the patients with LNR #0.1, #0.2, #0.4, and >0.4 were 75%, 66%, 50%, and 33%, respectively (p<0.001). There were substantial differences with statistical significance among the four groups in LRFS and DMFS as well. Univariate analysis showed that age, gender, preoperative CEA level, number of harvested LNs, and tumor size did not have a prognostic impact on OS, LRFS, DMFS, and DFS (Table 2). According to the log rank test, however, lower T and N stages, lower LNR, Fig. 2. Overall survival rate according to lymph node ratio. Fig. 3. Disease-free survival rate according to lymph node ratio.
4 Prognostic value of LNR in rectal cancer d Y. S. KIM et al. 799 Table 2. Univariate analysis according to clinicopathologic factors in 232 patients Characteristics Patients (n) OS LRFS DMFS DFS Total Age # > p Gender Male Female p CEA level (ng/ml) # > p T stage p <0.001 <0.001 <0.001 <0.001 N stage p < <0.001 <0.001 LN examined # > p Differentiation Well Moderately Poorly Others p < Tumor size (cm) # > p LNR # # # > p < <0.001 <0.001 Operation APR LAR Others p Abbreviations: OS = overall survival; LRFS = local recurrence-free survival; DMSF = distant metastasis-free survival; DSF = disease-free survival. Other abbreviations as in Table 1. more-differentiated tumors, and lower anterior resection were associated with significantly improved OS, DMFS, and DFS; T stage, grade of differentiation, type of surgery, and LNR had significant prognostic value in LRFS. Cox regression analysis for OS that included the number of positive LNs as a continuous variable and other variables with prognostic significance in univariate analysis showed that the prognostic value of LNR remained, as well as poorly differentiated tumor (Table 3). Compared with the group with LNR #0.1, the hazard ratios of the groups with LNR #0.2, #0.4, and >0.4 were (p = 0.623), (p = 0.047), and (p = 0.005), respectively. Similarly for DFS, when compared with the group having LNR #0.1, the hazard ratios of the groups with LNR #0.2, #0.4, and >0.4 were (p = 0.686), (p = 0.024), and (p < 0.001), respectively. The prognostic value of T stage and LNR remained significant on multivariate analysis for DFS. To determine whether LNR had a prognostic significance on survival in each N stage, we performed survival analyses based on LNR in patients with N1 and N2 tumors, respectively. We
5 800 I. J. Radiation Oncology d Biology d Physics Volume 74, Number 3, 2009 Table 3. Multivariate analysis for overall survival in 232 patients Factors p HR >95% CI T stage T1 1 Referent T T T N stage N1 1 Referent N LNR #0.1 1 Referent # # > Differentiation Well 1 Referent Moderately Poorly Operation LAR 1 Referent APR Abbreviations: HR = hazard ratio; CI = confidence interval. Other abbreviations as in Table 1. found that LNR had a prognostic impact on OS in both patients with N1 (p = 0.032) and N2 (p = 0.034) tumors (Table 4). Five-year OS was inversely related to LNR for both N1 and N2 except for the group with N1 and LNR >0.4, which consisted of only 7 patients. Similar findings were also observed for DFS. Irrespective of the number of examined LNs, LNR also had a prognostic impact on survival in each subgroup (Table 5). DISCUSSION Postoperative chemoradiotherapy has become a standard treatment in patients with Stage II and III rectal cancer (23, 24). Local control, toxicities, and compliance to treatment favored preoperative chemoradiation although there was no significant difference in OS between pre- and postoperative chemoradiation(25). However, it should be noted that only Table 4. Survival rate by LNR in N1 and N2 disease Factors Patients (n) OS LRFS DMFS DFS N1 LNR # LNR # LNR # LNR > p N2 LNR # LNR # LNR # LNR > p Abbreviations as in Tables 1 and 2. Table 5. Survival rate by LNR in patients with #17 and >17 examined LNs Factors Patients (n) OS LRFS DMFS DFS Examined LNs #17 LNR # LNR # LNR # LNR > p Examined LNs >17 LNR # LNR # LNR # LNR > p <0.001 <0.001 Abbreviations as in Tables 1 and 2. half of the patients in the postoperative chemoradiation group received the planned treatment, likely contributing to their inferior clinical outcome. The most important advantage of postoperative treatment is accurate staging, particularly nodal status. We therefore reviewed the clinical data of patients who received adjuvant chemoradiotherapy, not those who received preoperative treatment. We found that the ear OS rate in 232 patients with Stage III rectal cancer was 69% (75% for N1 and 61% for N2 disease), superior to the OS rates reported in earlier randomized trials. A pooled analysis of patients in three North American Phase III trials who received adjuvant chemoradiation for rectal cancer (26) showed that the ear OS rates of patients with N1 and N2 disease were 65% and 52%, respectively. Because we used similar chemotherapy and radiotherapy regimens, the increased survival advantage reported here may have resulted, at least in part, from the surgical technique (TME) used. There have been few clinical evaluations of TME combined with postoperative chemoradiation, although one trial reported that the ear OS rate in patients with Stage II and Stage III tumors was 74% (25). In addition, because all 232 of our patients underwent a uniform TME performed by three colorectal-specialized surgeons at the same hospital, better clinical outcomes in terms of survival and local control could be achieved (27, 28). Although the number of examined LNs did not have a statistical effect on OS (p = 0.121), patients with more than 17 examined LNs showed a trend toward increased LRFS and DFS. A median of 17 LNs harvested per patient, a marker of appropriate surgery and pathologic examination, is thought to result in better LRFS and DFS (8, 29). There was a positive correlation between the numbers of involved and examined LNs (r = 0.429, p< 0.001), in agreement with previous findings showing that LN harvest correlated with tumor size, pathologist s interest, and number of positive LNs (3). The number of involved LNs also strongly correlated with LNR (r = 0.724, p<0.001), with a correlation between higher LNR and higher frequency of N2 disease. However, the number of examined LNs did not differ
6 Prognostic value of LNR in rectal cancer d Y. S. KIM et al. 801 significantly among the four LNR groups. Increased OS in the patients with more than 17 examined LNs did not reach statistical significance (77% vs. 63%, p = 0.121), which may have been due, at least in part, to the relatively small sample size. Number of examined LNs has been shown to correlate with better survival in patients with Stage III colorectal cancer (5 7); in those trials, 0 to 34% had rectal cancer. In some of these trials, the prognostic value of the number of LNs retrieved could not be assessed separately in patients with rectal cancer (6, 7). In other analyses, the number of examined LNs did not have a significant impact on survival (5, 29). Thus, to date, the impact of LN yield on survival of patients with Stage III rectal cancer has not been clear. Part of the prognostic value of the number of examined LNs is thought to be due to the Will Rogers phenomenon, or stage migration, as observed in stomach and breast cancer as well as in colorectal cancer (30). As demonstrated in reports on stomach cancer, the use of LNR-based staging decreases the incidence of stage migration by 50% (31, 32). LNR was also proven as an independent prognostic factor of both local recurrence and overall survival in the retrospective review of three North Central Cancer Treatment Group trials (20). In this analysis of 673 patients with Stage II/III rectal cancer, patients were categorized according to their LNR: LNR <0.25 (n = 355), #0.5 (n = 153), #0.75 (n = 66), and >0.75 (n = 68). Local recurrence rate increased as LNR increased: 10%, 14%, 34%, and 34%, respectively. Opposite findings were observed in overall survival: 70%, 55%, 39%, and 37%. These trends are in accordance with those of the present study (Table 2). Because TME was performed in every patients and because of more meticulous LN examination in the present study (18% of patients had 4 or fewer nodes examined, and 68% had fewer than 12 in the study by Stocchi et al. [20]), more favorable outcomes in terms of survival and local control could be gained, even when the patients with Stage III disease were assessed. Given the more constant denominator (i.e., the number of examined LNs), LNR may reflect the number of involved LNs, especially in patients who undergo meticulous LN dissection. Moreover, LNR can be influenced by suboptimal LN examination and can complement the drawback of current N staging (i.e., N2 when more than three LNs are involved, regardless of quantity). LNR is thought to have its own prognostic value for survival, besides N staging and the number of dissected LNs. The possible decrease in the incidence of stage migration and the differences in ear OS, LRFS, DMFS, and DFS in patients with each N stage seem to suggest the prognostic importance of LNR. Our study had several important limitations, including its relatively small sample size and its retrospective design. However, there have been few reports on the prognostic value of LNR in patients with Stage III rectal cancer. Moreover, LNR showed prognostic significance on multivariate analysis and in patients with each N stage, and there were noticeable disparities among the LNR groups in both OS and DFS curves. In contrast to postoperative chemoradiotherapy, several studies have shown that preoperative treatment decreased LN yield (33, 34), whereas other studies have reported that preoperative treatment had no effect on LN yield (3, 35). Prospective studies including larger numbers of patients are needed to determine the prognostic value of LNR in patients undergoing neoadjuvant chemoradiation followed by TME. In conclusion, we have shown here that LNR is an important prognostic factor in patients with Stage III rectal cancer who underwent TME followed by chemoradiation and should be considered a stratification factor in future randomized controlled trials. More-intensive or further chemotherapy is indicated for patients with higher LNR, because most treatment failures were distant metastases. REFERENCES 1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49: Compton C, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000;88: Thorn CC, Woodcock NP, Scott N, et al. What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis 2004;6: Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer. Hepatogastroenterology 2004;51: Edler D, Ohrling K, Hallstrom M, et al. The number of analyzed lymph nodes a prognostic factor in colorectal cancer. Acta Oncol 2007;46: George S, Primrose J, Talbot R, et al. Will Rogers revisited: Prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer 2006;95: Johnson PM, Porter GA, Ricciardi R, et al. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006;24: Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005;41: Tsai HL, Lu CY, Hsieh JS, et al. The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer. J Gastrointest Surg 2007;11: Yoshimatsu K, Ishibashi K, Umehara A, et al. How many lymph nodes should be examined in Dukes B colorectal cancer? Determination on the basis of cumulative survival rate. Hepatogastroenterology 2005;52: Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003;169: Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: Results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245: Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007;141:
7 802 I. J. Radiation Oncology d Biology d Physics Volume 74, Number 3, Sierzega M, Popiela T, Kulig J, et al. The ratio of metastatic/ resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 2006;33: Truong PT, Berthelet E, Lee J, et al. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005;103: van der Wal BC, Butzelaar RM, van der Meij S, et al. Axillary lymph node ratio and total number of removed lymph nodes: Predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 2002;28: Voordeckers M, Vinh-Hung V, Van de Steene J, et al. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 2004;70: Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005;23: Lee HY, Choi HJ, Park KJ, et al. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol 2007;14: Stocchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathologic variables in rectal cancer: A United States community and cooperative group report. J Clin Oncol 2001;19: Lee JH, Lee JH, Ahn JH, et al. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary report. J Clin Oncol 2002;20: Yoon SM, Kim JH, Kim JC, et al. Comparison of preoperative and postoperative radiotherapy with capecitabine in locally advanced rectal cancer: A preliminary report of a phase III randomized trial (Abstr.). Int J Radiat Oncol Biol Phys 2007; 63(Suppl.):S Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal cancer. N Engl J Med 1985;312: Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324: Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351: Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: A pooled analysis. Int J Radiat Oncol Biol Phys 2002;54: Kockerling F, Reymond MA, Altendorf-Hofmann A, et al. Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 1998;16: Porter GA, Soskolne CL, Yakimets WW, et al. Surgeon-related factors and outcome in rectal cancer. Ann Surg 1998;227: Tepper JE, O Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19: Derwinger K, Carlsson G, Gustavsson B. Stage migration in colorectal cancer related to improved lymph node assessment. Eur J Surg Oncol 2007;33: Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002;9: Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratiobased lymph node staging in gastric carcinoma. Ann Surg Oncol 2002;9: Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001;19: Wichmann MW, Muller C, Meyer G, et al. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 2002;137: Kim J, Huynh R, Abraham I, et al. Number of lymph nodes examined and its impact on colorectal cancer staging. Am Surg 2006;72:
Lymph node ratio as a prognostic factor in stage III colon cancer
Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com
More informationLong Term Outcomes of Preoperative versus
RESEARCH ARTICLE Long Term Outcomes of Preoperative versus Postoperative Concurrent Chemoradiation for Locally Advanced Rectal Cancer: Experience from Ramathibodi Medical School in Thailand Pichayada Darunikorn
More informationNumber of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival
Number of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD, Dae Joon Kim, MD, Seong Yong Park, MD, Kil Dong Kim,
More informationPrognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer
Original Article Journal of the Korean Society of http://dx.doi.org/10.3393/jksc.2011.27.5.252 pissn 2093-7822 eissn 2093-7830 Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer Jin
More informationAdjuvant Chemotherapy for Rectal Cancer: Are we making progress?
Adjuvant Chemotherapy for Rectal Cancer: Are we making progress? Hagen Kennecke, MD, MHA, FRCPC Division Of Medical Oncology British Columbia Cancer Agency October 25, 2008 Objectives Review milestones
More informationThe Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer
Original Article The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer Chen Qiu, MD,* Wei Dong, MD,* Benhua Su, MBBS, Qi Liu, MD,* and Jiajun Du, PhD Introduction:
More informationPrognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer
Hou et al. World Journal of Surgical Oncology (2018) 16:198 https://doi.org/10.1186/s12957-018-1504-5 REVIEW Open Access Prognostic significance of metastatic lymph node ratio: the lymph node ratio could
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationDifferential lymph node retrieval in rectal cancer: associated factors and effect on survival
Original Article Differential lymph node retrieval in rectal cancer: associated factors and effect on survival Cedrek McFadden 1, Brian McKinley 1, Brian Greenwell 2, Kaylee Knuckolls 1, Patrick Culumovic
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationLower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance
Original Article Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance Dedrick Kok Hong Chan 1,2, Ker-Kan Tan 1,2 1 Division of Colorectal Surgery, University
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GASTROINTESTINAL RECTAL CANCER GI Site Group Rectal Cancer Authors: Dr. Jennifer Knox, Dr. Mairead McNamara 1. INTRODUCTION 3 2. SCREENING AND
More informationClinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer
Original Article Journal of the Korean Society of http://dx.doi.org/10.3393/jksc.2011.27.5.260 pissn 2093-7822 eissn 2093-7830 Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer Yo
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationCase Conference. Craig Morgenthal Department of Surgery Long Island College Hospital
Case Conference Craig Morgenthal Department of Surgery Long Island College Hospital Neoadjuvant versus Adjuvant Radiation Therapy in Rectal Carcinoma Epidemiology American Cancer Society statistics for
More informationOriginal Article The value of lymph node ratio in the prediction of rectal cancer patient survival after preoperative chemoradiotherapy
Int J Clin Exp Pathol 2018;11(12):5992-6001 www.ijcep.com /ISSN:1936-2625/IJCEP0086231 Original Article The value of lymph node ratio in the prediction of rectal cancer patient survival after preoperative
More informationLymph node harvest in rectal cancer surgery following neoadjuvant chemoradiotherapy
Journal of Surgery 2014; 2(2): 27-1 Published online April 10, 2014 (http://www.sciencepublishinggroup.com/j/js) doi: 10.1148/j.js.20140202.1 Lymph node harvest in rectal cancer surgery following neoadjuvant
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/18952 holds various files of this Leiden University dissertation. Author: Dekker, Jan Willem Title: Risk and outcome in colorectal cancer surgery Date:
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/38705 holds various files of this Leiden University dissertation. Author: Gijn, Willem van Title: Rectal cancer : developments in multidisciplinary treatment,
More informationThe impact of operation center and the prognostic factors on the outcome of patients with stage II and stage III colorectal cancer
Turkish Journal of Cancer Volume 38, No. 4, 28 175 The impact of operation center and the prognostic factors on the outcome of patients with stage II and stage III colorectal cancer ABDULLAH BÜYÜKÇELİK
More informationStaging of cancer patients is an important tool for the selection
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:997 1003 Improvement of Staging by Combining Tumor and Treatment Parameters: The Value for Prognostication in Rectal Cancer MARLEEN J. E. M. GOSENS,* J.
More informationCarcinoma del retto: Highlights
Carcinoma del retto: Highlights Stefano Cordio Struttura Complessa di Oncologia Medica ARNAS Garibaldi Catania Roma 17 Febbraio 2018 Disclosures Advisory Committee, research funding and speakers bureau
More informationLog odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection
Original Article Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection Mingjian Yang 1,2, Hongdian Zhang 1,2, Zhao Ma 1,2, Lei Gong 1,2, Chuangui Chen
More informationMini J.Elnaggar M.D. Radiation Oncology Ochsner Medical Center 9/23/2016. Background
Mini J.Elnaggar M.D. Radiation Oncology Ochsner Medical Center 9/23/2016 Background Mostly adenocarcinoma (scc possible, but treated like anal cancer) 39, 220 cases annually Primary treatment: surgery
More informationORIGINAL ARTICLE. International Journal of Surgery
International Journal of Surgery (2013) 11(S1), S90 S94 Contents lists available at ScienceDirect International Journal of Surgery journal homepage: www.journal-surgery.net ORIGINAL ARTICLE Lymph node
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationIs adjuvant radiotherapy warranted in resected pt1-2 node-positive rectal cancer?
Peng et al. Radiation Oncology 2013, 8:290 RESEARCH Open Access Is adjuvant radiotherapy warranted in resected pt1-2 node-positive rectal cancer? Junjie Peng 1,2, Xinxiang Li 1,2, Ying Ding 3, Debing Shi
More informationNeoadjuvant Therapy for Rectal Cancer is Overrated. Joon H. Lee, Research Resident University of Colorado 8/31/2009
Neoadjuvant Therapy for Rectal Cancer is Overrated Joon H. Lee, Research Resident University of Colorado 8/31/2009 Objectives Brief overview of staging rectal cancer Current guidelines for evaluation and
More informationAdvances in gastric cancer: How to approach localised disease?
Advances in gastric cancer: How to approach localised disease? Andrés Cervantes Professor of Medicine Classical approach to localised gastric cancer Surgical resection Pathology assessment and estimation
More informationThe impact of lymph node examination on survival of stage II colorectal cancer patients: Are 12 nodes adequate?
Formosan Journal of Surgery (2011) 44, 176e180 Available online at www.sciencedirect.com journal homepage: www.e-fjs.com ORIGINAL ARTICLE The impact of lymph node examination on survival of stage II colorectal
More informationJinsil Seong, MD 1 Ik Jae Lee, MD, PhD 2 Joon Seong Park, MD 3 Dong Sup Yoon, MD 3 Kyung Sik Kim, MD 4 Woo Jung Lee, MD 4 Kyung Ran Park, MD 5
pissn 1598-2998, eissn 25-9256 Cancer Res Treat. 216;48(2):583-595 Original Article http://dx.doi.org/1.4143/crt.215.91 Open Access Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy
More informationRECTAL CANCER CLINICAL CASE PRESENTATION
RECTAL CANCER CLINICAL CASE PRESENTATION Francesco Sclafani Medical Oncologist, Clinical Research Fellow The Royal Marsden NHS Foundation Trust, London, UK esmo.org Disclosure I have nothing to declare
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal drainage, after hepatic resection, 159 160 Ablation, radiofrequency, for hepatocellular carcinoma, 160 161 Adenocarcinoma, pancreatic.
More informationColorectal Cancer Dashboard
Process Risk Assessment Presence or absence of cancer in first-degree blood relatives documented for patients with colorectal cancer Percent of patients with colorectal cancer for whom presence or absence
More informationBackground: Patients and methods: Results: Conclusions:
Chapter 7 7 Results of European pooled analysis of IORT containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastase
More informationThe evaluation of metastatic lymph node ratio staging system in gastric cancer
Gastric Cancer (2013) 16:309 317 DOI 10.1007/s10120-012-0190-1 ORIGINAL ARTICLE The evaluation of metastatic lymph node ratio staging system in gastric cancer Yanbing Zhou Jizhun Zhang Shougen Cao Yu Li
More informationTerapia neoadyuvante en cáncer de recto Estado del arte Mauricio Lema Medina MD Clínica de Oncología Astorga / Clínica SOMA - Medellín, Colombia
Terapia neoadyuvante en cáncer de recto Estado del arte Mauricio Lema Medina MD Clínica de Oncología Astorga / Clínica SOMA - Medellín, Colombia Temario Generalidades Adyuvancia en colon y recto FU / Capecitabina
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationDoes the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma?
Does the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma? The Harvard community has made this article openly available. Please share how this access benefits
More informationCOLON AND RECTAL CANCER
COLON AND RECTAL CANCER Mark Sun, MD Clinical Associate Professor of Surgery University of Minnesota No disclosures Objectives 1) Understand the epidemiology, management, and prognosis of colon and rectal
More informationThe role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis
Original Article The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis Croix C. Fossum 1, Jasim Y. Alabbad 2, Lindsay B. Romak 3, Christopher L.
More informationARTICLE IN PRESS. doi: /j.ijrobp METAPLASTIC CARCINOMA OF THE BREAST: A RETROSPECTIVE REVIEW
doi:10.1016/j.ijrobp.2005.08.024 Int. J. Radiation Oncology Biol. Phys., Vol. xx, No. x, pp. xxx, 2005 Copyright 2005 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/05/$ see front matter
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationPrognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy
pissn : 293-582X, eissn : 293-564 J Gastric Cancer 26;6(3):6-66 http://dx.doi.org/.523/jgc.26.6.3.6 Original Article Prognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy
More informationPMRT for N1 breast cancer :CONS. Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center
PMRT for N1 breast cancer :CONS Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center DBCG 82 b & c Overgaard et al Radiot Oncol 2007 1152 pln(+), 8 or more nodes removed Systemic
More informationRadiotherapy for rectal cancer. Karin Haustermans Department of Radiation Oncology
Radiotherapy for rectal cancer Karin Haustermans Department of Radiation Oncology O U T L I N E RT with TME surgery? Neoadjuvant or adjuvant RT? 5 x 5 Gy or long-course CRT? RT with new drugs? Selection
More informationDifferential effect of concurrent chemotherapy regimen on clinical outcomes of preoperative chemoradiotherapy for locally advanced rectal cancer
JBUON 2019; 24(2): 470-478 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Differential effect of concurrent chemotherapy regimen on clinical outcomes
More informationA Retrospective Study of Survival and Patterns of Failure in Gastric Cancer after Adjuvant Chemoradiation
Med. J. Cairo Univ., Vol. 82, No. 2, December: 131-138, 2014 www.medicaljournalofcairouniversity.net A Retrospective Study of Survival and Patterns of Failure in Gastric Cancer after Adjuvant Chemoradiation
More informationResearch Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy
International Surgical Oncology Volume 2012, Article ID 307670, 7 pages doi:10.1155/2012/307670 Research Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy
More information3/8/2014. Case Presentation. Primary Treatment of Anal Cancer. Anatomy. Overview. March 6, 2014
Case Presentation Primary Treatment of Anal Cancer 65 year old female presents with perianal pain, lower GI bleeding, and anemia with Hb of 7. On exam 6 cm mass protruding through the anus with bulky R
More informationOriginal Article. Mi Young Kim, MD 1, Jin Hee Kim, MD, PhD 1, Yonghoon Kim, MD 2, Sang Jun Byun, MD 3. Introduction
Original Article Radiat Oncol J 16;34(4):29734 https://doi.org/1.3857/roj.16.1879 pissn 223419 eissn 22343156 Postoperative radiotherapy appeared to improve the disease free survival rate of patients with
More informationRe-irradiation in recurrent rectal cancer: single institution experience
Original Article Re-irradiation in recurrent rectal cancer: single institution experience Rasha Mohammad Abdel Latif, Ghada E. El-Adawei, Wael El-Sada Clinical Oncology & Nuclear Medicine Department, Mansoura
More informationShort course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?
Short communication Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided? Michael A. Cummings 1, Kenneth Y. Usuki 1, Fergal J. Fleming 2, Mohamedtaki A. Tejani
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationPrognostic and predictive value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection
/, 2017, Vol. 8, (No. 41), pp: 70841-70846 Prognostic and predictive value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection Yinbo Chen 1,*, Cong Li 2,*, Yian Du 3, Qi
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationEvaluation of the Efficacy of Modified De Gramont and Modified FOLFOX4 Regimens for Adjuvant Therapy of Locally Advanced Rectal Cancer
Efficacy of Modified De Gramont and FOLFOX4 Regimens for Locally Advanced Rectal Cancer RESEARCH COMMUNICATION Evaluation of the Efficacy of Modified De Gramont and Modified FOLFOX4 Regimens for Adjuvant
More informationEarly Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh
Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh What is Early rectal cancer? pt1t2n0m0 Predictors for LN involvement Size Depth Intramural
More informationBone Metastases in Muscle-Invasive Bladder Cancer
Journal of the Egyptian Nat. Cancer Inst., Vol. 18, No. 3, September: 03-08, 006 AZZA N. TAHER, M.D.* and MAGDY H. KOTB, M.D.** The Departments of Radiation Oncology* and Nuclear Medicine**, National Cancer
More informationIs Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?
Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Lee H, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Choi DW Department of Surgery, Samsung Medical Center Sungkyunkwan
More informationJournal of Breast Cancer
Journal of Breast Cancer ORIGINAL ARTICLE J Breast Cancer 215 June; 18(2): 167-172 Treatment Outcome of Breast Cancer with Pathologically Proven Synchronous Ipsilateral Supraclavicular Lymph Node Metastases
More informationPreoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer
Evidence-Based Series 2-4 Version 2 A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Preoperative or Postoperative Therapy for the Management of Patients with
More informationPulmonary Resection for Metastases from Colorectal Cancer
ORIGINAL ARTICLE Pulmonary Resection for Metastases from Colorectal Cancer Paul M. van Schaik, MD,* Ewout A. Kouwenhoven, MD, PhD,* Robert J. Bolhuis, MD,* Bonne Biesma, MD, PhD, and Koop Bosscha, MD,
More informationSurgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database
Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Hadi Khan, MD 1, Adam J. Olszewski, MD 2 and Ponnandai S. Somasundar, MD 1 1 Department
More informationWhen to Integrate Surgery for Metatstatic Urothelial Cancers
When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male
More informationPrognostic value of visceral pleura invasion in non-small cell lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung
More informationReduced Lymph Node Harvest after Neoadjuvant Chemotherapy in Gastric Cancer
The Journal of International Medical Research 2011; 39: 2086 2095 Reduced Lymph Node Harvest after Neoadjuvant Chemotherapy in Gastric Cancer Z-M WU 1, R-Y TENG 2, J-G SHEN 2, S-D XIE 2, C-Y XU 2,3 AND
More informationLymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.
Thomas Jefferson University Jefferson Digital Commons Department of Surgery Faculty Papers Department of Surgery 1-1-2012 Lymph node ratio is an important and independent prognostic factor for patients
More informationNovel Methods of Lymph Node Evaluation for Predicting the Prognosis of Colorectal Cancer Patients with Inadequate Lymph Node Harvest
pissn 1598-2998, eissn 25-9256 Cancer Res Treat. 216;48(1):216-224 Original Article http://dx.doi.org/1.4143/crt.214.312 Open Access Novel Methods of Lymph Node Evaluation for Predicting the Prognosis
More informationRob Glynne-Jones Mount Vernon Cancer Centre
ESMO Preceptorship Programme Colorectal Cancer Valencia May 2018 State of the art: Standards of care in preoperative treatment for rectal cancer Rob Glynne-Jones Mount Vernon Cancer Centre My Disclosures:
More informationInterval between Surgery and Radiation Therapy Is an Important Prognostic Factor in Treatment of Rectal Cancer
pissn 1598-2998, eissn 2005-9256 Cancer Res Treat. 2012;44(3):187-194 Original Article http://dx.doi.org/10.4143/crt.2012.44.3.187 Open Access Interval between Surgery and Radiation Therapy Is an Important
More informationOutcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy
Original Article Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy Jessica Frakes 1, Eric A. Mellon 1, Gregory
More informationLymph node ratio as a prognostic factor in head and neck cancer patients
Chen et al. Radiation Oncology (2015) 10:181 DOI 10.1186/s13014-015-0490-9 RESEARCH Open Access Lymph node ratio as a prognostic factor in head and neck cancer patients Chien-Chih Chen 1*, Jin-Ching Lin
More informationClinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients
Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide
More informationOutcomes of pancreaticoduodenectomy in patients with metastatic cancer
Korean J Hepatobiliary Pancreat Surg 2014;18:147-151 http://dx.doi.org/.14701/kjhbps.2014.18.4.147 Original Article Outcomes of pancreaticoduodenectomy in patients with metastatic cancer Joo Hwa Kwak,
More informationSignificance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories
Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling
More informationSMJ Singapore Medical Journal
SMJ Singapore Medical Journal ONLINE FIRST PUBLICATION Online first papers have undergone full scientific review and copyediting, but have not been typeset or proofread. To cite this article, use the DOIs
More informationIndex. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationCurrent Issues and Controversies in the Management of Rectal Cancer
Current Issues and Controversies in the Management of Rectal Cancer Ghazi M. Nsouli MD 11 th Annual Congress of the Lebanese Society of Gastroenterology November 16, 2012 GMN 20121116 1 Staging of rectal
More informationPATHOLOGIC FACTORS PROGNOSTIC OF SURVIVAL IN PATIENTS WITH GI TRACT AND PANCREATIC CARCINOMA TREATED WITH NEOADJUVANT THERAPY
PATHOLOGIC FACTORS PROGNOSTIC OF SURVIVAL IN PATIENTS WITH GI TRACT AND PANCREATIC CARCINOMA TREATED WITH NEOADJUVANT THERAPY Jeannelyn S. Estrella, MD Department of Pathology The UT MD Anderson Cancer
More informationMeta analysis in Rectal Cancer
Meta analysis in Rectal Cancer Dr. Monica Irukulla Professor and Head Department of Radiation Oncology Nizam s Institute of Medical Sciences hyderabad Areas of meta analysis in rectal cancers Epidemiology
More informationCOLON AND RECTAL CANCER
No disclosures COLON AND RECTAL CANCER Mark Sun, MD Clinical Assistant Professor of Surgery University of Minnesota Colon and Rectal Cancer Statistics Overall Incidence 2016 134,490 new cases 8.0% of all
More informationTreatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy
Treatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy Kyoung Ju Kim 1, Seung Jae Huh 1, Jung-Hyun Yang 2, Won Park 1, Seok Jin Nam
More informationCOLORECTAL CARCINOMA
QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF COLORECTAL CARCINOMA Ministry of Health Malaysia Malaysian Society of Colorectal Surgeons Malaysian Society of Gastroenterology & Hepatology Malaysian
More informationPrognostic factors in squamous cell anal cancers
Prognostic factors in squamous cell anal cancers Zainul Abedin Kapacee Year 4-5 Intercalating Medical Student, University of Manchester Dr. Shabbir Susnerwala, Mr. Nigel Scott Dr. Falalu Danwata, Dr. Marcus
More informationSurgical Management of Advanced Stage Colon Cancer. Nathan Huber, MD 6/11/14
Surgical Management of Advanced Stage Colon Cancer Nathan Huber, MD 6/11/14 Colon Cancer Overview Approximately 50,000 attributable deaths per year Colorectal cancer is the 3 rd most common cause of cancer-related
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/38705 holds various files of this Leiden University dissertation. Author: Gijn, Willem van Title: Rectal cancer : developments in multidisciplinary treatment,
More informationRESEARCH COMMUNICATION
DOI:http://dx.doi.org/10.7314/APJCP.2012.13.1.199 RESEARCH COMMUNICATION Prognostic Significance of CYFRA21-1, CEA and Hemoglobin in Patients with Esophageal Squamous Cancer Undergoing Concurrent Chemoradiotherapy
More informationOutcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study
Original Article Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Elmer E. van Eeghen 1, Frank den Boer 2, Sandra D. Bakker 1,
More informationTreatment of Locally Advanced Rectal Cancer: Current Concepts
Treatment of Locally Advanced Rectal Cancer: Current Concepts James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS Case Presentation
More informationAre there the specific prognostic factors for triplenegative subtype of early breast cancers (pt1-2n0m0)?
Are there the specific prognostic factors for triplenegative subtype of early breast cancers (pt1-2n0m0)? Department of General Surgery, Anam Hospital, Korea University, College of Medicine, 126-, Anam-dong
More informationCurrent Status of Adjuvant Therapy for Colorectal Cancer
Review Article [1] May 01, 2004 By Michael J. O connell, MD [2] Adjuvant therapy with chemotherapy and/or radiation therapy in addition to surgery improves outcome for patients with high-risk carcinomas
More informationintent treatment be in the elderly?
Gastric cancer: How strong can curative intent treatment be in the elderly? Caio Max S. Rocha Lima, M.D. Professor of Medicine University of Miami & Sylvester Cancer Center Gastric cancer: epidemiology
More informationSurgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study
Original article Annals of Gastroenterology (2013) 26, 346-352 Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Subhankar Chakraborty
More informationWHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?
CANCER STAGING TNM and prognosis in CRC WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER? Alessandro Lugli, MD Institute of Pathology University of Bern Switzerland Maastricht, June 19
More informationClinical features and prognostic factors in patients with nasopharyngeal carcinoma relapse after primary treatment
Page 1 of 7 Clinical features and prognostic factors in patients with nasopharyngeal carcinoma relapse after primary treatment X Peng 1, SF Chen 2, C Du 2 *, P Yang 2, SX Liang 2, G Zhang 3, X Dong 4 *,
More informationRectal cancer: Poster Session Review
AIOM PostASCO GI Roma, 5-6 febbraio 2016 Rectal cancer: Poster Session Review Sara Lonardi SS Trattamento Multidisciplinare Tumori Colorettali - UOC Oncologia Medica 1 Dipartimento di Oncologia Clinica
More information